1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 1:Patient demographic and clinical data
Pediatric Patients (n = 24) Adult Patients (n = 20) Age (mean) (yr) 9.21 ± 3.59 32.4 ± 10.94 Sex (male) (No.) (%) 16 (67) 3 (15) Clinical presentation (No.) (%) Focal neurologic symptoms 17 (71) 13 (65) Seizure 3 (13) 4 (20) Headache 5 (21) 3 (15) Infarction 9 (38) 14 (70) Hemorrhage 0 (0) 1 (5) Comorbidities (No.) (%)a 3 (8) 0 (0)
↵a There were 2 patients with neurofibromatosis type 1 and 1 patient with systemic lupus erythematosus.